• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Diagnosis, Prevention, and Management of Fetal Growth Restriction (FGR).胎儿生长受限(FGR)的诊断、预防与管理
J Pers Med. 2024 Jun 28;14(7):698. doi: 10.3390/jpm14070698.
2
Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians.胎儿生长受限与宫内生长受限:法国妇产科医师学院临床实践指南
Eur J Obstet Gynecol Reprod Biol. 2015 Oct;193:10-8. doi: 10.1016/j.ejogrb.2015.06.021. Epub 2015 Jul 2.
3
Fetal growth restriction: current knowledge.胎儿生长受限:当前认知
Arch Gynecol Obstet. 2017 May;295(5):1061-1077. doi: 10.1007/s00404-017-4341-9. Epub 2017 Mar 11.
4
Human placental microperfusion and microstructural assessment by intra-voxel incoherent motion MRI for discriminating intrauterine growth restriction: a pilot study.应用体素内不相干运动 MRI 对胎盘微血管灌注和微结构进行评估,以鉴别胎儿宫内生长受限:一项初步研究。
J Matern Fetal Neonatal Med. 2022 Dec;35(25):9667-9674. doi: 10.1080/14767058.2022.2050365. Epub 2022 Mar 15.
5
Prognostic value of diffusion-weighted magnetic resonance imaging of brain in fetal growth restriction: results of prospective multicenter study.胎儿生长受限的脑弥散加权磁共振成像的预后价值:前瞻性多中心研究结果。
Ultrasound Obstet Gynecol. 2020 Dec;56(6):893-900. doi: 10.1002/uog.21926.
6
Interventions affecting the nitric oxide pathway versus placebo or no therapy for fetal growth restriction in pregnancy.干预影响一氧化氮通路与安慰剂或无治疗妊娠胎儿生长受限。
Cochrane Database Syst Rev. 2023 Jul 10;7(7):CD014498. doi: 10.1002/14651858.CD014498.
7
Evidence of adaptation of maternofetal transport of glutamine relative to placental size in normal mice, and in those with fetal growth restriction.正常小鼠和胎儿生长受限小鼠中,胎母谷氨酸转运与胎盘大小相关的适应性证据。
J Physiol. 2019 Oct;597(19):4975-4990. doi: 10.1113/JP278226. Epub 2019 Aug 27.
8
Down-regulation of placental neuropilin-1 in fetal growth restriction.胎盘神经纤毛蛋白-1 在胎儿生长受限中的下调。
Am J Obstet Gynecol. 2016 Feb;214(2):279.e1-279.e9. doi: 10.1016/j.ajog.2015.09.068. Epub 2015 Sep 26.
9
A Study of the Literature on Intrauterine Treatment Options for Chronic Placental Insufficiency with Intrauterine Growth Restriction Using Intrauterine Intravascular Amino Acid Supplementation.一项关于使用宫内血管内补充氨基酸对伴有胎儿生长受限的慢性胎盘功能不全进行宫内治疗方案的文献研究。
Life (Basel). 2023 May 23;13(6):1232. doi: 10.3390/life13061232.
10
Guideline No. 442: Fetal Growth Restriction: Screening, Diagnosis, and Management in Singleton Pregnancies.指南 442:胎儿生长受限:单胎妊娠的筛查、诊断与管理。
J Obstet Gynaecol Can. 2023 Oct;45(10):102154. doi: 10.1016/j.jogc.2023.05.022.

引用本文的文献

1
Cardiac biomarkers in term newborns with common pathological conditions during the first 24 hours postpartum.产后24小时内患有常见病理状况的足月儿的心脏生物标志物。
Biochem Med (Zagreb). 2025 Oct 15;35(3):030702. doi: 10.11613/BM.2025.030702. Epub 2025 Aug 15.
2
Survivin Expression in Placentas with Intrauterine Growth Restriction.存活素在宫内生长受限胎盘组织中的表达
Biomedicines. 2025 Jun 27;13(7):1576. doi: 10.3390/biomedicines13071576.
3
Investigation of potential protein biomarkers for the screening of placental-mediated fetal growth restriction disorders using targeted proteomics Olink technology.使用靶向蛋白质组学Olink技术研究用于筛查胎盘介导的胎儿生长受限疾病的潜在蛋白质生物标志物。
Front Immunol. 2025 May 16;16:1542034. doi: 10.3389/fimmu.2025.1542034. eCollection 2025.
4
Emerging Prognostic and Predictive Biomarkers for Human Cytomegalovirus Infection During Pregnancy: Unmet Needs and Future Perspectives.孕期人巨细胞病毒感染的新兴预后和预测生物标志物:未满足的需求与未来展望
Viruses. 2025 May 14;17(5):705. doi: 10.3390/v17050705.
5
From infection to infertility: a review of the role of human papillomavirus-induced oxidative stress on reproductive health and infertility.从感染到不孕不育:人乳头瘤病毒诱导的氧化应激对生殖健康和不孕不育影响的综述
Eur J Med Res. 2025 Apr 28;30(1):339. doi: 10.1186/s40001-025-02605-4.
6
Phosphodiesterase Inhibitors in Fetal Growth Restriction: Do Not Forget to Consider Fetal Sex and Subcellular Compartmentation.胎儿生长受限中的磷酸二酯酶抑制剂:别忘了考虑胎儿性别和亚细胞区室化
Biomedicines. 2024 Oct 14;12(10):2329. doi: 10.3390/biomedicines12102329.

本文引用的文献

1
Investigation and Care of a Small-for-Gestational-Age Fetus and a Growth Restricted Fetus (Green-top Guideline No. 31).小于胎龄儿和胎儿生长受限的调查与处理(绿皮书指南第31号)
BJOG. 2024 Aug;131(9):e31-e80. doi: 10.1111/1471-0528.17814. Epub 2024 May 13.
2
Labor management and neonatal outcomes in cardiotocography categories II and III (Review).胎心监护II类和III类中的产时管理与新生儿结局(综述)
Med Int (Lond). 2024 Apr 1;4(3):27. doi: 10.3892/mi.2024.151. eCollection 2024 May-Jun.
3
Maternal Blood Adipokines and Their Association with Fetal Growth: A Meta-Analysis of the Current Literature.母体血液中的脂肪因子及其与胎儿生长的关联:当前文献的荟萃分析
J Clin Med. 2024 Mar 14;13(6):1667. doi: 10.3390/jcm13061667.
4
Color Doppler ultrasound in high-low risk pregnancies and its relationship to fetal outcomes: a cross-sectional study.彩色多普勒超声在高危与低危妊娠中的应用及其与胎儿结局的关系:一项横断面研究。
Front Pediatr. 2024 Feb 20;11:1221766. doi: 10.3389/fped.2023.1221766. eCollection 2023.
5
Fetal and Placental Causes of Elevated Serum Alpha-Fetoprotein Levels in Pregnant Women.孕妇血清甲胎蛋白水平升高的胎儿及胎盘原因。
J Clin Med. 2024 Jan 14;13(2):466. doi: 10.3390/jcm13020466.
6
Opioid, methamphetamine, and polysubstance use: perinatal outcomes for the mother and infant.阿片类药物、甲基苯丙胺和多物质使用:母婴围产期结局
Front Pediatr. 2023 Dec 18;11:1305508. doi: 10.3389/fped.2023.1305508. eCollection 2023.
7
Oxidative Stress in Pregnancy.妊娠中的氧化应激。
Biomolecules. 2023 Dec 9;13(12):1768. doi: 10.3390/biom13121768.
8
Placental Findings in Infants Gestational Age < 34 Weeks and Impact on Short-Term Outcomes.妊娠龄<34 周婴儿的胎盘表现及其对短期结局的影响。
J Mother Child. 2023 Nov 3;27(1):168-175. doi: 10.34763/jmotherandchild.20222601.d-23-00017. eCollection 2023 Jun 1.
9
Maternal and Newborn Characteristics-A Comparison between Healthy and Thrombophilic Pregnancy.孕产妇和新生儿特征——健康妊娠与易栓症妊娠的比较
Life (Basel). 2023 Oct 19;13(10):2082. doi: 10.3390/life13102082.
10
Defining trophoblast injury patterns in the transcriptomes of dysfunctional placentas.定义功能失调胎盘转录组中滋养层细胞损伤模式。
Placenta. 2023 Nov;143:87-90. doi: 10.1016/j.placenta.2023.10.010. Epub 2023 Oct 17.

胎儿生长受限(FGR)的诊断、预防与管理

Diagnosis, Prevention, and Management of Fetal Growth Restriction (FGR).

作者信息

Tsikouras Panagiotis, Antsaklis Panos, Nikolettos Konstantinos, Kotanidou Sonia, Kritsotaki Nektaria, Bothou Anastasia, Andreou Sotiris, Nalmpanti Theopi, Chalkia Kyriaki, Spanakis Vlasis, Iatrakis George, Nikolettos Nikolaos

机构信息

Department of Obstetrics and Gynecology, Democritus University of Thrace, 68100 Alexandroupolis, Greece.

Department of Obstetrics and Gynecology Medical School, University Hospital Alexandra, National and Kapodistrian University of Athens, 12462 Athens, Greece.

出版信息

J Pers Med. 2024 Jun 28;14(7):698. doi: 10.3390/jpm14070698.

DOI:10.3390/jpm14070698
PMID:39063953
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11278205/
Abstract

Fetal growth restriction (FGR), or intrauterine growth restriction (IUGR), is still the second most common cause of perinatal mortality. The factors that contribute to fetal growth restriction can be categorized into three distinct groups: placental, fetal, and maternal. The prenatal application of various diagnostic methods can, in many cases, detect the deterioration of the fetal condition in time because the nature of the above disorder is thoroughly investigated by applying a combination of biophysical and biochemical methods, which determine the state of the embryo-placenta unit and assess the possible increased risk of perinatal failure outcome and potential for many later health problems. When considering the potential for therapeutic intervention, the key question is whether it can be utilized during pregnancy. Currently, there are no known treatment interventions that effectively enhance placental function and promote fetal weight development. Nevertheless, in cases with fetuses diagnosed with fetal growth restriction, immediate termination of pregnancy may have advantages not only in terms of minimizing perinatal mortality but primarily in terms of reducing long-term morbidity during childhood and maturity.

摘要

胎儿生长受限(FGR),或宫内生长受限(IUGR),仍然是围产期死亡的第二大常见原因。导致胎儿生长受限的因素可分为三个不同的组:胎盘、胎儿和母体。在许多情况下,各种诊断方法的产前应用能够及时检测到胎儿状况的恶化,因为通过结合生物物理和生化方法对上述疾病的本质进行了深入研究,这些方法可以确定胚胎 - 胎盘单位的状态,并评估围产期失败结局的可能增加风险以及许多后期健康问题的可能性。在考虑治疗干预的可能性时,关键问题是它是否可以在孕期使用。目前,尚无已知的治疗干预措施能有效增强胎盘功能并促进胎儿体重增长。然而,对于诊断为胎儿生长受限的胎儿,立即终止妊娠可能不仅在降低围产期死亡率方面具有优势,而且主要在减少儿童期和成年期的长期发病率方面具有优势。